Literature DB >> 10467540

Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control.

R R Nelson1.   

Abstract

Intrinsic resistance to vancomycin in gram-positive bacteria presumably predates acquired vancomycin resistance in enterococci but it has only recently generated interest. Intrinsically resistant enterococci possessing the vanC gene and the non-enterococcal genera Leuconostoc, Lactobacillus, Pediococcus and Erysipelothrix are known to cause human infection. This review examines the available data on their identification, resistance mechanisms, epidemiology, clinical infections and antimicrobial susceptibility. Intrinsically vancomycin-resistant gram-positives are usually opportunistic pathogens. Although serious infections may occur, treatment options remain available. No additional infection control measures for the intrinsically resistant genera appear justified with currently available evidence, although vigilance should be maintained to detect future changes in susceptibility patterns.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467540     DOI: 10.1053/jhin.1998.0605

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  11 in total

1.  Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan.

Authors:  K T Luh; P R Hsueh; L J Teng; H J Pan; Y C Chen; J J Lu; J J Wu; S W Ho
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  First report of peritonitis caused by the vancomycin-resistant coccus Pediococcus pentosaceus in a patient on continuous ambulatory peritoneal dialysis.

Authors:  Shefali Gupta; Chinmoy Sahu; Soumyabrata Nag; Uma Shankar Saha; Narayan Prasad; Kashi Nath Prasad
Journal:  Access Microbiol       Date:  2019-04-23

3.  Antibacterial and Antibiofilm Activity of Lactic Acid Bacteria Isolated from Traditional Artisanal Milk Cheese from Northeast China Against Enteropathogenic Bacteria.

Authors:  Xingyang Cui; Yunjia Shi; Shanshan Gu; Xin Yan; Hongyan Chen; Junwei Ge
Journal:  Probiotics Antimicrob Proteins       Date:  2018-12       Impact factor: 4.609

Review 4.  Update on antibiotic resistance in foodborne Lactobacillus and Lactococcus species.

Authors:  Chiara Devirgiliis; Paola Zinno; Giuditta Perozzi
Journal:  Front Microbiol       Date:  2013-10-08       Impact factor: 5.640

5.  Effects of high hydrostatic pressure on bacterial growth on human ossicles explanted from cholesteatoma patients.

Authors:  Steffen Dommerich; Hagen Frickmann; Jürgen Ostwald; Tobias Lindner; Andreas Erich Zautner; Kathleen Arndt; Hans Wilhelm Pau; Andreas Podbielski
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 6.  Infectious causes of cholesteatoma and treatment of infected ossicles prior to reimplantation by hydrostatic high-pressure inactivation.

Authors:  Wycliffe Omurwa Masanta; Rebecca Hinz; Andreas Erich Zautner
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 7.  Antimicrobial resistance mechanisms and potential synthetic treatments.

Authors:  Junaid Ali; Qasim A Rafiq; Elizabeth Ratcliffe
Journal:  Future Sci OA       Date:  2018-02-05

8.  Beneficial properties of lactic acid bacteria naturally present in dairy production.

Authors:  Monique Colombo; Nathália P A Castilho; Svetoslav D Todorov; Luís Augusto Nero
Journal:  BMC Microbiol       Date:  2018-12-19       Impact factor: 3.605

9.  Septicemia and Aortic Valve Endocarditis due to Erysipelothrix rhusiopathiae in a Homeless Man.

Authors:  Dean Campbell; Mark Cowan
Journal:  Case Rep Infect Dis       Date:  2013-04-10

10.  Potential of Maintaining a Healthy Vaginal Environment by Two Lactobacillus Strains Isolated from Cocoa Fermentation.

Authors:  Ana Clara Correia Melgaço; Wallace Felipe Blohem Pessoa; Herbert Pina Freire; Milena Evangelista de Almeida; Maysa Santos Barbosa; Rachel Passos Rezende; Jorge Timenetsky; Lucas Miranda Marques; Carla Cristina Romano
Journal:  Biomed Res Int       Date:  2018-09-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.